Asset Management Corp’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$228K Buy
+1,485
New +$245K 0.18% 114
2022
Q3
Sell
-3,075
Closed -$467K 164
2022
Q2
$439K Hold
3,075
0.28% 90
2022
Q1
$530K Buy
+3,075
New +$518K 0.26% 91
2021
Q2
Sell
-2,050
Closed -$268 186
2021
Q1
$268 Buy
+2,050
New +$297K 0.11% 147

Other funds holding MRNA

Asset Management Corp's MRNA Position: Q1 2023 in Review

Asset Management Corp opened a new position in Moderna (MRNA) in Q1 2023: 1,485 shares worth $228K. The stake represents 0.18% of the portfolio and ranks #114 among its holdings. This is a return to the name: Asset Management Corp previously reported a position in MRNA as recently as Q2 2022.

Asset Management Corp first reported a position in MRNA in Q1 2021 and has held it in 4 quarters since. The position peaked at $530K in Q1 2022. 1,016 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Asset Management Corp held 1,485 shares of Moderna worth $228K as of Q1 2023.
  • Moderna was a new Asset Management Corp position in Q1 2023.
  • Moderna made up 0.18% of Asset Management Corp's portfolio in Q1 2023, its #114 holding.
  • Asset Management Corp first reported a position in Moderna in Q1 2021 and has held it in 4 quarters since.
  • Asset Management Corp's Moderna position peaked at $530K in Q1 2022.
  • 1,016 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Asset Management Corp's 13F filing for Q1 2023, filed 14 Apr 2023.